BIM
ATYR

BlackRock Investment Management’s aTyr Pharma ATYR Stock Holding History

BlackRock Investment Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6K Hold
209
– – ﹤0.01% 3741
2016
Q3 		$9K Hold
209
– – ﹤0.01% 3642
2016
Q2 		$8K Sell
209
-1,345
-87% -$62.5K ﹤0.01% 3726
2016
Q1 		$86K Buy
1,554
+32
+2% +$2.43K ﹤0.01% 3242
2015
Q4 		$209K Buy
1,522
+5
+0.3% +$711 ﹤0.01% 3226
2015
Q3 		$218K Sell
1,517
-28
-2% -$6.38K ﹤0.01% 3238
2015
Q2 		$401K Buy
+1,545
New +$480K ﹤0.01% 3186

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

BlackRock Investment Management's ATYR Position: Q4 2016 in Review

BlackRock Investment Management held its aTyr Pharma (ATYR) position steady in Q4 2016 at 209 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3741.

BlackRock Investment Management first reported a position in ATYR in Q2 2015 and has held it in 7 quarters since. The position peaked at $401K in Q2 2015. 52 funds tracked by Wall St. Rank hold ATYR as of Q4 2016.

  • BlackRock Investment Management held 209 shares of aTyr Pharma worth $6K as of Q4 2016.
  • BlackRock Investment Management left its aTyr Pharma share count unchanged in Q4 2016.
  • aTyr Pharma made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3741 holding.
  • BlackRock Investment Management first reported a position in aTyr Pharma in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Investment Management's aTyr Pharma position peaked at $401K in Q2 2015.
  • 52 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.